CPC A61L 15/18 (2013.01) [A61L 15/26 (2013.01); A61L 15/425 (2013.01); A61L 15/46 (2013.01); A61L 24/0015 (2013.01); A61L 24/0036 (2013.01); A61L 24/0094 (2013.01); A61F 13/00017 (2013.01); A61L 2300/106 (2013.01); A61L 2300/404 (2013.01); A61L 2400/16 (2013.01)] | 20 Claims |
1. A system comprising:
a composite including a shape memory polymer (SMP) foam, a hydrogel (HG), and a therapeutic agent;
wherein: (a) the SMP foam includes open cells and has first and second states, and (b) the hydrogel is included within the open cells;
wherein the composite is configured to: (a) be located in a hemorrhagic tissue with the SMP foam in the first state; and (b) expand the SMP foam to the second state in the hemorrhagic tissue when the SMP foam is plasticized at 37° C. depressing a glass transition temperature (Tg) of the SMP foam to below 25° C.
|